IP18-18: Risk of urolithiasis and renal protection associated with benzbromarone versus allopurinol: Insights from the trinetx global network

IP18-18: Risk of urolithiasis and renal protection associated with benzbromarone versus allopurinol: Insights from the trinetx global network

Friday, May 15, 2026 1:00 PM to 3:00 PM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!